Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Manan Pareek, R. Preston Mason & Deepak L. Bhatt. (2022) Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides. Expert Opinion on Drug Safety 21:1, pages 31-42.
Read now
Read now
Nadeem Tajuddin, Ali Shaikh & Amir Hassan. (2016) Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity 9, pages 109-118.
Read now
Read now
Terry A Jacobson. (2014) Perspectives on a new prescription omega-3 fatty acid, icosapent ethyl, for hypertriglyceridemia. Clinical Lipidology 9:2, pages 149-161.
Read now
Read now
Christie M Ballantyne, Rene A Braeckman & Paresh N Soni. (2013)
Icosapent ethyl for the treatment of hypertriglyceridemia. Expert Opinion on Pharmacotherapy 14:10, pages 1409-1416.
Read now
Read now
Articles from other publishers (24)
Acharya Balkrishna, Rashmi Mittal & Vedpriya Arya. 2023. Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer. Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer
198
207
.
Marjia Sultana, Eng-Seng Chan, Janarthanan Pushpamalar & Wee Sim Choo. (2022) Advances in extrusion-dripping encapsulation of probiotics and omega-3 rich oils. Trends in Food Science & Technology 123, pages 69-86.
Crossref
Crossref
Bridget A. Hannon, William D. Fairfield, Bryan Adams, Theodore Kyle, Mason Crow & Diana M. Thomas. (2020) Use and abuse of dietary supplements in persons with diabetes. Nutrition & Diabetes 10:1.
Crossref
Crossref
Bernard Cuenoud, Isabelle Rochat, Maria Gosoniu, Lenaick Dupuis, Evan Berk, Anke Jaudszus, Jochen Mainz, Gaudenz Hafen, Maurice Beaumont & Cristina Cruz-Hernandez. (2020) Monoacylglycerol Form of Omega-3s Improves Its Bioavailability in Humans Compared to Other Forms. Nutrients 12:4, pages 1014.
Crossref
Crossref
Klaus W. Lange. 2005. Bailey's Industrial Oil and Fat Products. Bailey's Industrial Oil and Fat Products
1
17
.
Daniel E. Hilleman, Barbara S. Wiggins & Michael B. Bottorff. (2020) Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review. Advances in Therapy 37:2, pages 656-670.
Crossref
Crossref
Kathleen M. Gura, Kara L. Calkins & Mark Puder. (2020) Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert. Nutrition in Clinical Practice 35:1, pages 108-118.
Crossref
Crossref
Chandrajeet Singh, Arpana Sharma, Mahendra Bishnoi, Kanthi K. Kondepudi & Ravindra Pal Singh. 2020. Advances in Agri-Food Biotechnology. Advances in Agri-Food Biotechnology
287
332
.
Klaus W. Lange, Yukiko Nakamura, Ning Chen, Jianjun Guo, Shigehiko Kanaya, Katharina M. Lange & Shiming Li. (2019) Diet and medical foods in Parkinson’s disease. Food Science and Human Wellness 8:2, pages 83-95.
Crossref
Crossref
Kristine Scordo & Kim Anne Pickett. (2017) CE. AJN, American Journal of Nursing 117:1, pages 24-31.
Crossref
Crossref
Jan Philipp Schuchardt, Juliane Neubronner, Robert C. Block, Clemens von Schacky & Andreas Hahn. (2014) Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids 91:4, pages 129-134.
Crossref
Crossref
Rashmi S. Sharma, Raechel C. Joy, Carol J. Boushey, Mario G. Ferruzzi, Alexei P. Leonov & Megan A. McCrory. (2014) Effects of Para-Aminobenzoic Acid (PABA) Form and Administration Mode on PABA Recovery in 24-Hour Urine Collections. Journal of the Academy of Nutrition and Dietetics 114:3, pages 457-463.
Crossref
Crossref
Daniel E. HillemanMark A. Malesker. (2014) Potential Benefits of Icosapent Ethyl on the Lipid Profile: Case Studies. Clinical Medicine Insights: Cardiology 8, pages CMC.S13571.
Crossref
Crossref
Cengiz Kara, Figen Gunindi, Ala Ustyol & Murat Aydin. (2014) Vitamin D Intoxication Due to an Erroneously Manufactured Dietary Supplement in Seven Children. Pediatrics 133:1, pages e240-e244.
Crossref
Crossref
Howard Weintraub. (2013) Update on marine omega-3 fatty acids: Management of dyslipidemia and current omega-3 treatment options. Atherosclerosis 230:2, pages 381-389.
Crossref
Crossref
Richard P. Haslam, Noemi Ruiz-Lopez, Peter Eastmond, Maurice Moloney, Olga Sayanova & Johnathan A. Napier. (2013) The modification of plant oil composition via metabolic engineering-better nutrition by design. Plant Biotechnology Journal 11:2, pages 157-168.
Crossref
Crossref
Tiffany Nicholson, Haidar Khademi & Mohammed H. Moghadasian. (2013) The role of marine n-3 fatty acids in improving cardiovascular health: a review. Food & Function 4:3, pages 357.
Crossref
Crossref
Alexander V. LyubimovSheela PaiBir & Sadayappan V. Rahavendran. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
48
.
Victor M. Ye & Sujata K. Bhatia. (2012) Metabolic engineering for the production of clinically important molecules: Omega-3 fatty acids, artemisinin, and taxol. Biotechnology Journal 7:1, pages 20-33.
Crossref
Crossref
Mélanie Bousquet, Frédéric Calon & Francesca Cicchetti. (2011) Impact of omega-3 fatty acids in Parkinson's disease. Ageing Research Reviews 10:4, pages 453-463.
Crossref
Crossref
Todd C. Rideout, Scott V. Harding, Christopher P.F. Marinangeli & Peter J.H. Jones. (2010) Combination drug–diet therapies for dyslipidemia. Translational Research 155:5, pages 220-227.
Crossref
Crossref
Peter J. Gillies & Penny M. Kris-Etherton. (2010) Opportunities and Challenges in Nutrigenetics/Nutrigenomics: Building Industry-Academia Partnerships. Journal of Nutrigenetics and Nutrigenomics 3:4-6, pages 296-304.
Crossref
Crossref
Rodney A. Velliquette, Peter J. Gillies, Penny M. Kris-Etherton, John W. Green, Guixiang Zhao & John P. Vanden Heuvel. (2009) Regulation of human stearoyl-CoA desaturase by omega-3 and omega-6 fatty acids: Implications for the dietary management of elevated serum triglycerides. Journal of Clinical Lipidology 3:4, pages 281-288.
Crossref
Crossref
Heinz Rupp. (2009) Omacor® (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia. Advances in Therapy 26:7, pages 675-690.
Crossref
Crossref